Novartis Ag (NVS) EBIT Margin (2009 - 2024)
Novartis Ag recorded quarterly EBIT Margin of 32.08% in Q2 2024, up 31.49% quarter-over-quarter from 24.4% in Q4 2023, and up 1035.0% year-over-year from 2.83% in Q3 2023.
Novartis Ag's EBIT Margin history runs 13 years deep, the most recent figure standing at 32.08% for Q2 2024.
- In Q2 2024, EBIT Margin rose 1035.0% year-over-year to 32.08%; the TTM figure through Jun 2024 stood at 43.97% (up 1859.0% YoY), while the FY2025 annual figure was 32.36%, up 345.0% from the prior year.
- EBIT Margin came in at 32.08% for Q2 2024 at Novartis Ag, up from 24.4% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 194.69% in Q3 2021 to a low of 18.83% in Q1 2020.
- A 5-year average of 79.23% and a median of 65.27% in 2023 frame the typical range for EBIT Margin.
- On a YoY basis, EBIT Margin climbed as much as 12986 bps in 2021 and fell as far as 15280 bps in 2021.
- Novartis Ag's EBIT Margin stood at 153.72% in 2020, then sank by 99 bps to 0.92% in 2021, then jumped by 11604 bps to 107.48% in 2022, then sank by 77 bps to 24.4% in 2023, then surged by 31 bps to 32.08% in 2024.
- According to Business Quant data, EBIT Margin over the past three periods registered 32.08%, 24.4%, and 21.73% for Q2 2024, Q4 2023, and Q2 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Novartis Ag | 107,124,802.25 Bn | 107,124,802.25 Bn | - | - |
| 2 | Eli Lilly | 969.00 Bn | 963.72 Bn | 16.22 Bn | 47.98% |
| 3 | Johnson & Johnson | 539.46 Bn | 517.41 Bn | 15.96 Bn | 26.44% |
| 4 | AbbVie | 376.92 Bn | 367.57 Bn | 10.78 Bn | 26.60% |
| 5 | Merck | 285.00 Bn | 279.35 Bn | 12.09 Bn | -47.46% |
| 6 | Amgen | 177.58 Bn | 165.55 Bn | 5.87 Bn | 30.94% |
| 7 | Gilead Sciences | 163.22 Bn | 155.50 Bn | 5.52 Bn | 37.16% |
| 8 | Pfizer | 145.86 Bn | 133.09 Bn | -1.21 Bn | -286.83% |
| 9 | Bristol Myers Squibb | 111.90 Bn | 101.44 Bn | 8.07 Bn | -1.58% |
| 10 | Gsk | 88.34 Bn | 83.66 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 32.08% |
| Dec 31, 2023 | 24.40% |
| Jun 30, 2023 | 21.73% |
| Mar 31, 2023 | 98.46% |
| Dec 31, 2022 | 107.48% |
| Sep 30, 2022 | 159.75% |
| Jun 30, 2022 | 18.70% |
| Mar 31, 2022 | 153.31% |
| Dec 31, 2021 | 0.92% |
| Sep 30, 2021 | 194.69% |
| Jun 30, 2021 | 22.25% |
| Mar 31, 2021 | 111.03% |
| Dec 31, 2020 | 153.72% |
| Sep 30, 2020 | 165.97% |
| Jun 30, 2020 | 21.98% |
| Mar 31, 2020 | -18.83% |
| Mar 31, 2019 | 116.17% |
| Dec 31, 2018 | 103.95% |
| Sep 30, 2018 | 140.39% |
| Jun 30, 2018 | 8.91% |
| Mar 31, 2018 | 192.92% |
| Dec 31, 2017 | 150.99% |
| Sep 30, 2017 | 203.13% |
| Jun 30, 2017 | 1,181.35% |
| Dec 31, 2016 | 15.64% |
| Sep 30, 2016 | 189.30% |
| Jun 30, 2016 | 238.99% |
| Mar 31, 2016 | 183.07% |
| Dec 31, 2015 | 332.31% |
| Sep 30, 2015 | 267.59% |
| Mar 31, 2015 | 226.67% |
| Dec 31, 2014 | 419.54% |
| Sep 30, 2014 | 409.68% |
| Mar 31, 2014 | 812.05% |
| Dec 31, 2010 | 2,169,166.84% |
| Jun 30, 2010 | 2,509.39% |
| Dec 31, 2009 | 88.48% |
| Jun 30, 2009 | 2,569.69% |
| Mar 31, 2009 | 24.17% |